4 unchanged sentences
Date of Filing
+Added: Agreement and Plan of Merger, dated June 22, 2023, by and among Aeglea BioTherapeutics, Inc.
+Added: Aspen Merger Sub I, Inc., Sequoia Merger Sub II, LLC and Spyre Therapeutics, Inc.
Restated Certificate of Incorporation
Amended and Restated Bylaws
−Removed: Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.
−Removed: Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.
−Removed: Certification of the Principal Executive Officer pursuant to 18 U.S.C.
−Removed: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of the Principal Financial Officer pursuant to 18 U.S.C.
+Added: Certificate of Designation of Series A Non-Voting Convertible Preferred Stock
+Added: Securities Purchase Agreement, dated as of June 22, 2023, by and among Aeglea BioTherapeutics, Inc.
+Added: and each purchaser thereto
+Added: Form of Registration Rights Agreement, by and among Aeglea BioTherapeutics, Inc.
+Added: and each purchaser thereto
+Added: Offer Letter, dated June 22, 2023, by and between Aeglea BioTherapeutics, Inc.
+Added: and Cameron Turtle
+Added: Antibody Discovery and Option agreement, dated May 25, 2023, by and between Paragon Therapeutics, Inc., Parapyre Holding LLC and Spyre Therapeutics, Inc.
+Added: First Amendment to the Aeglea BioTherapeutics, Inc.
+Added: 2016 Equity Incentive Plan
+Added: First Amendment to the Aeglea BioTherapeutics, Inc.
+Added: 2018 Equity Inducement Plan
+Added: Amended and Restated Spyre 2023 Equity Incentive Plan
+Added: Form of Stock Option Agreement under the Aeglea BioTherapeutics, Inc.
+Added: 2018 Equity Inducement Plan
+Added: Asset Purchase Agreement, dated July 27, 2023, by and between Aeglea BioTherapeutics, Inc.
+Added: and Immedica Pharma AB
+Added: Certification of the Principal Executive and Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.
+Added: Incorporate by
+Added: Date of Filing
+Added: Certification of the Principal Executive and Financial Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
6 unchanged sentences
Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: The cover page from this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL and contained in Exhibit 101
+Added: The cover page from this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL and contained in Exhibit 101
+Added: + Indicates management contract or compensatory plan.
+Added: # Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.
(1) The certifications on Exhibit 32 hereto are deemed not “filed”
2 unchanged sentences
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: AEGLEA BIOTHERAPEUTICS, INC.
−Removed: /s/ Jeffrey Goldberg
−Removed: Jeffrey Goldberg
−Removed: Chief Executive Officer
−Removed: (Principal Executive Officer)
−Removed: Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
+Added: August 11, 2023
AEGLEA BIOTHERAPEUTICS, INC.
1 unchanged sentence
Jonathan Alspaugh
−Removed: Chief Financial Officer
−Removed: (Principal Financial Officer and duly Authorized Signatory)
+Added: President and Chief Financial Officer
+Added: (Principal Executive Officer, Principal Financial Officer and duly Authorized Signatory)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.